Application research of Oliceridine in conscious intubation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400087374

Enrollment

Unknown

Registered

2024-07-25

Start date

2024-08-01

Completion date

Unknown

Last updated

2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difficult airway

Interventions

Test group:Oliceridine

control group:sufentanil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-65, ASA grade I-II, undergoing elective surgery; 2. Mallampati score of 3-4 for difficult airway assessment; Age range: 18-65 years old 3. Difficult tracheal intubation is expected, and conscious tracheal intubation is planned.

Exclusion criteria

Exclusion criteria: If any of the following criteria are met, this research plan must be excluded: 1. Pregnant women 2. Complex thyroid surgery or complex mediastinal and esophageal surgery 3. Merge with a history of severe cardiovascular disease; 4. Patients undergoing tracheotomy 5. Patients who are not suitable for conscious tracheal intubation 6. Patient refuses to participate in the study 7. Drug allergies, etc

Design outcomes

Primary

Measure	Time frame
hemodynamic indices;Ramsay Sedation Rating;Anesthesia Effect Score;operation time;Wake-up time;Total dosage of propofol;patient satisfaction;	—

Countries

China

Contacts

Public ContactYang Pingliang

The First Affiliated Hospital of Chengdu Medical College

yangpingliang@126.com+86 181 4006 4602

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026